DNA Methylation Consistency Implicates the Primary Tumor Cell Origin of Recurrent Hepatocellular Carcinoma

References

• Vivarelli M , MontaltiR , RisalitiA . Multimodal treatment of hepatocellular carcinoma on cirrhosis: an update . World J. Gastroenterol.19 ( 42 ), 7316 – 7326 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Yazici C , NiemeyerDJ , IannittiDA , RussoMW . Hepatocellular carcinoma and cholangiocarcinoma: an update. Expert Rev . Gastroenterol. Hepatol.8 ( 1 ), 63 – 82 ( 2014 ).
   Google Scholar
• Dupont-Bierre E , CompagnonP , RaoulJL , FayetG , de Lajarte-ThirouardAS , BoudjemaK . Resection of hepatocellular carcinoma in noncirrhotic liver: analysis of risk factors for survival . J. Am. Coll. Surg.201 ( 5 ), 663 – 670 ( 2005 ).
   PubMed Web of Science ®Google Scholar
• Lim KC , ChowPK , AllenJC , SiddiquiFJ , ChanES , TanSB . Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria . Br. J. Surg.99 ( 12 ), 1622 – 1629 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Dhir M , LydenER , SmithLM , AreC . Comparison of outcomes of transplantation and resection in patients with early hepatocellular carcinoma: a meta-analysis . HPB (Oxford)14 ( 9 ), 635 – 645 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Arii S , TeramotoK , KawamuraTet al. Characteristics of recurrent hepatocellular carcinoma in Japan and our surgical experience . J. Hepatobiliary Pancreat. Surg.8 ( 5 ), 397 – 403 ( 2001 ).
   PubMedGoogle Scholar
• Choi GH , KimDH , KangCMet al. Prognostic factors and optimal treatment strategy for intrahepatic nodular recurrence after curative resection of hepatocellular carcinoma . Ann. Surg. Oncol.15 ( 2 ), 618 – 629 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Reya T , MorrisonSJ , ClarkeMF , WeissmanIL . Stem cells, cancer, and cancer stem cells . Nature414 ( 6859 ), 105 – 111 ( 2001 ).
   PubMed Web of Science ®Google Scholar
• Visvader JE , LindemanGJ . Cancer stem cells in solid tumours: accumulating evidence and unresolved questions . Nat. Rev. Cancer8 ( 10 ), 755 – 768 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Kyo S , MaidaY , InoueM . Stem cells in endometrium and endometrial cancer: accumulating evidence and unresolved questions . Cancer Lett.308 ( 2 ), 123 – 133 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Pantel K , Alix-PanabieresC , RiethdorfS . Cancer micrometastases . Nat. Rev. Clin. Oncol.6 ( 6 ), 339 – 351 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Fan ST , YangZF , HoDW , NgMN , YuWC , WongJ . Prediction of posthepatectomy recurrence of hepatocellular carcinoma by circulating cancer stem cells: a prospective study . Ann. Surg.254 ( 4 ), 569 – 576 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Yamamoto T , KajinoK , KudoM , SasakiY , ArakawaY , HinoO . Determination of the clonal origin of multiple human hepatocellular carcinomas by cloning and polymerase chain reaction of the integrated hepatitis B virus DNA . Hepatology29 ( 5 ), 1446 – 1452 ( 1999 ).
   PubMed Web of Science ®Google Scholar
• Ng IO , GuanXY , PoonRT , FanST , LeeJM . Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis . J. Pathol.199 ( 3 ), 345 – 353 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• He B , TangZY , LiuKD , ZhouG . Analysis of the cellular origin of hepatocellular carcinoma by p53 genotype . J. Cancer Res. Clin. Oncol.122 ( 12 ), 763 – 766 ( 1996 ).
   PubMed Web of Science ®Google Scholar
• Xu X , XingB , HuMet al. Recurrent hepatocellular carcinoma cells with stem cell-like properties: possible targets for immunotherapy . Cytotherapy12 ( 2 ), 190 – 200 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Wang Y , ChengJ , XuCet al. Quantitative methylation analysis reveals gender and age differences in p16INK4a hypermethylation in hepatitis B virus-related hepatocellular carcinoma . Liver Int.32 ( 3 ), 420 – 428 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Jiang S , YangZ , LiWet al. Re-evaluation of the carcinogenic significance of hepatitis B virus integration in hepatocarcinogenesis . PLoS ONE7 ( 9 ), e40363 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Yang XR , XuY , YuBet al. High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma . Gut59 ( 7 ), 953 – 962 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Goeppert B , SchmezerP , DutruelCet al. Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms . Hepatology52 ( 6 ), 2023 – 2033 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Moribe T , IizukaN , MiuraTet al. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search . Int. J. Oncol.33 ( 5 ), 949 – 958 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Moribe T , IizukaN , MiuraTet al. Methylation of multiple genes as molecular markers for diagnosis of a small, well-differentiated hepatocellular carcinoma . Int. J. Cancer125 ( 2 ), 388 – 397 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Nishida N , KudoM , NagasakaT , IkaiI , GoelA . Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma . Hepatology56 ( 3 ), 994 – 1003 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Yu J , TaoQ , CheungKFet al. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors . Hepatology48 ( 2 ), 508 – 518 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Xie B , ZhouJ , YuanLet al. Epigenetic silencing of Klotho expression correlates with poor prognosis of human hepatocellular carcinoma . Hum. Pathol.44 ( 5 ), 795 – 801 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Ammerpohl O , PratschkeJ , SchafmayerCet al. Distinct DNA methylation patterns in cirrhotic liver and hepatocellular carcinoma . Int. J. Cancer.130 ( 6 ), 1319 – 1328 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Ren J , HeW , ZhangRet al. RASSF2A promoter methylation in hepatitis B virus-related hepatocellular carcinogenesis and its correlation with elevated serum alpha-fetoprotein level . J Huazhong Univ Sci Technolog Med Sci.29 ( 3 ), 309 – 312 ( 2009 ).
   PubMedGoogle Scholar
• Kuo CC , LinCY , ShihYLet al. Frequent methylation of HOXA9 gene in tumor tissues and plasma samples from human hepatocellular carcinomas . Clin. Chem. Lab. Med.52 ( 8 ), 1235 – 1245 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Tao R , LiJ , XinJet al. Methylation profile of single hepatocytes derived from hepatitis B virus-related hepatocellular carcinoma . PLoS ONE6 ( 5 ), e19862 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Xu XL , XingBC , HanHBet al. The properties of tumor-initiating cells from a hepatocellular carcinoma patient’s primary and recurrent tumor . Carcinogenesis31 ( 2 ), 167 – 174 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Oishi N , YamashitaT , KanekoS . Molecular biology of liver cancer stem cells . Liver Cancer3 ( 2 ), 71 – 84 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Guo Z , LiLQ , JiangJH , OuC , ZengLX , XiangBD . Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma . World J. Gastroenterol.20 ( 8 ), 2098 – 2106 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Yin X , LiYW , JinJJet al. The clinical and prognostic implications of pluripotent stem cell gene expression in hepatocellular carcinoma . Oncol. Lett.5 ( 4 ), 1155 – 1162 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Yin X , LiYW , ZhangBHet al. Coexpression of stemness factors Oct4 and Nanog predict liver resection . Ann. Surg. Oncol.19 ( 9 ), 2877 – 2887 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Arzumanyan A , FriedmanT , NgIO , ClaytonMM , LianZ , FeitelsonMA . Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells?Cancer Res.71 ( 10 ), 3701 – 3708 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Kimura O , KondoY , KogureTet al. Expression of EpCAM increases in the hepatitis B related and the treatment-resistant hepatocellular carcinoma . Biomed. Res. Int.2014 , 172913 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Yasui M , HaradaA , NonamiTet al. Potentially multicentric hepatocellular carcinoma: clinicopathologic characteristics and postoperative prognosis . World J. Surg.21 ( 8 ), 860 – 864 , 864 – 865 ( 1997 ).
   PubMed Web of Science ®Google Scholar
• Kaibori M , MatsuiY , SaitoT , KamiyamaY . Risk factors for different patterns of recurrence after resection of hepatocellular carcinoma . Anticancer Res.27 ( 4C ), 2809 – 2816 ( 2007 ).
   PubMed Web of Science ®Google Scholar